MapLight Therapeutics director files Form 3

MapLight Therapeutics, Inc. director Babler Martin has filed an initial Form 3, which is the first statement of beneficial ownership for insiders.

Rhea-AI Filing Summary

MapLight Therapeutics, Inc. director Babler Martin has filed an initial Form 3, which is the first statement of beneficial ownership for insiders. The structured data shows no reported transactions or derivative positions in this filing, indicating it is a baseline ownership disclosure rather than a trade report.

Key Terms

Form 3, reportingPersons, ten percent owner

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3):"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reportingPersons regulatory

""reportingPersons": [ { "name": "Babler Martin" } ]"

ten percent owner regulatory

""is_ten_percent_owner": 0"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the MapLight Therapeutics (MPLT) Form 3 filing show?

The Form 3 shows that Babler Martin is a director of MapLight Therapeutics and is reporting initial beneficial ownership information. It is a baseline disclosure and, in this case, does not list any specific stock or option transactions.

Who is the reporting person in the MapLight Therapeutics (MPLT) Form 3?

The reporting person is Babler Martin, identified as a director of MapLight Therapeutics. Form 3 is required when someone becomes an insider, such as a director or officer, to document their starting ownership position in the company’s securities.

Does the MPLT Form 3 for Babler Martin report any stock trades?

No trades are reported in this Form 3. The transaction summary shows zero buys, sells, exercises, gifts, or other transactions. The filing functions solely as an initial ownership statement rather than a record of insider trading activity.

How is a Form 3 different from a Form 4 for MapLight Therapeutics (MPLT)?

Form 3 is an initial statement of beneficial ownership filed when someone becomes an insider. Form 4, by contrast, reports subsequent changes in that insider’s holdings, such as purchases, sales, option exercises, or other transactions affecting their position.

Why is Babler Martin’s director status important in the MPLT Form 3?

Director status makes Babler Martin a corporate insider, triggering ongoing reporting obligations. As a director, future changes in his MapLight Therapeutics holdings will typically be reported on Forms 4 or 5, giving investors visibility into insider ownership activity over time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/25/2026 - 05:47 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Babler Martin

(Last) (First) (Middle)

C/O MAPLIGHT THERAPEUTICS, INC.

800 CHESAPEAKE DRIVE

(Street)

REDWOOD CITY CALIFORNIA 94063

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/23/2026

3. Issuer Name and Ticker or Trading Symbol
MapLight Therapeutics, Inc. [ MPLT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Kristopher L. Hanson, Attorney-in-Fact	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)